Effects of the antimicrobial growth promoter tylosin on subclinical infection of pigs with Salmonella enterica serotype Typhimurium

OBJECTIVE: To determine whether feeding tylosin, an antimicrobial growth promoter, to pigs was associated with increased risk of infection with and excretion of Salmonella enterica serotype Typhimurium. ANIMALS: 17 healthy pigs. PROCEDURE: A commercial pelleted dry feed was given in 2 feeding trials. In trial A, 11 pigs were given feed with tylosin, 11 pigs were given feed without tylosin, and 11 pigs were given feed with tylosin before and feed without tylosin after inoculation with S Typhimurium. In trial B, 44 pigs were given feed that contained tylosin, and 44 pigs were given feed without tylosin. Three weeks after the start of each trial, pigs were orally inoculated with approximately 5 x 10(6) colony-forming units of S Typhimurium. Feces were examined for S Typhimurium, using semiquantitative microbiologic techniques before and for 5 or 6 weeks after inoculation. Serum antibody titers against S enterica were measured by use of ELISA. RESULTS: None of the pigs developed clinical signs of salmonellosis. However, after inoculation, S Typhimurium was isolated from feces of most pigs, and all but 2 pigs developed serum antibodies against S enterica. Significant differences were not detected between experimental and control groups in either trial. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicate that tylosin fed as an antimicrobial growth promoter to pigs may not be an important factor in promoting infection with or excretion of S enterica serotype Typhimurium.     

Influence of antibiotics used as feed additives on the immune effect of erysipelas live vaccine in swine

To investigate the influence of antibiotics used as feed additives on the immune response to erysipelas live vaccine, the pig inoculation test was applied. Avilamycin, oxytetracycline quaternary salt, enramycin, virginiamycin and tylosin phosphate were selected as test antibiotics. Five experimental feeds containing each antibiotic at the highest concentration permitted for feed additives in Japan, and the basal diet lacking antibiotics were examined. Twenty-nine pigs were divided into six groups. At first all the groups were fed with the antibiotic-free basal diet for 7 days, and then each group received the experimental feeds. On the 14th day after feeding with test feeds all the pigs, except for one control pig in each group, were immunized with the vaccine and all the pigs were then challenge-exposed to a virulent strain of Erysipelothrix rhusiopathiae 14 days after vaccination. The clinical response was observed every day for 14 days. In all the groups, most of the vaccinated pigs did not develop any clinical signs of acute erysipelas after the challenge exposure, whereas non-vaccinated control pigs died or showed severe generalized erythema with profound depression and anorexia. No differences in the protection against the challenge exposure were observed among the groups. Therefore, the present results suggest that these selected antibiotics would not interfere with the immune effect of the vaccine if given at the usual concentrations used for feed additives.     

Antibiotic resistance in anaerobic and coliform bacteria from the intestinal tract of swine fed therapeutic and subtherapeutic concentrations of chlortetracycline

Chlortetracycline (CTC) resistance in anaerobic and coliform bacteria was examined in the large intestines of two groups of growing pigs that had received antibiotic-free diets since weaning. One group of pigs was from a low resistance herd (LR) that had not received antibiotics for 8 yr, while the other group of pigs was from a high resistance herd (HR) that routinely received antibiotics. After a 20-d adjustment period in a common production facility, LR pigs on an antibiotic-free diet had lower proportions of anaerobes (27%) and coliforms (22%) that were resistant to 25 micrograms CTC/ml than did similarly fed HR pigs (81 and 48%, respectively). Continued maintenance of LR and HR pigs on the antibiotic-free diet in a common production facility tended to increase resistance in anaerobes and coliforms from LR pigs to levels comparable with those in HR pigs at the end of an 85-d feeding trial, but not after 14 d. Administration of CTC in the feed at therapeutic (220 micrograms/g for 14 d) and growth-promoting (27.5 micrograms/g for 85 d) levels markedly increased percentages of resistant anaerobes and coliforms in LR pigs, but not in HR pigs after 14 d. Similar antibiotic effects were not seen at the end of the 85-d trial. These data demonstrate that, while exposure to antibiotics in feed may increase resistance in intestinal populations, other factors such as environment, cross-contamination and herd history can also influence the observed level of antibiotic resistance in swine.     

3-Acetyl-4'-isovaleryl tylosin for prevention of swine dysentery

The 21 field isolates of Treponema hyodysenteriae which were tested were sensitive to 3-acetyl-4'-isovaleryl tylosin (AIV); the minimal inhibitory concentration was 0.25 to 16 micrograms/ml. 3-Acetyl-4'-isovaleryl tylosin administered prophylactically to pigs at concentrations of 5 to 100 mg/kg of feed and tylosin at 110 mg/kg of feed for 28 or 31 days prevented swine dysentery induced by tylosin-sensitive T hyodysenteriae strain SQ2; 15 nonmedicated, inoculated control pigs had bloody diarrhea, and 9 pigs died. In 2 additional trials, AIV administered prophylactically for 28 days at 55 or 110 mg/kg of feed prevented swine dysentery induced by tylosin-insensitive T hyodysenteriae strain B204. All of the inoculated principal pigs medicated with AIV at 55 or 110 mg/kg of feed or carbadox at 55 mg/kg of feed and the noninoculated sentinel pigs for each group had solid feces throughout the 56-day trial. In the nonmedicated, inoculated control groups, bloody diarrhea began at 4 to 5 days after inoculation was done, and 9 of 10 principal pigs and 6 of 9 sentinel pigs had dysentery; 2 pigs died. In the groups medicated with AIV at 27.5 or 5.5 mg/kg of feed, all 5 principal pigs and 3 or 4 sentinel pigs in each group had dysentery; 3 or 4 pigs in each group died. In the group medicated with tylosin at 110 mg/kg of feed, 7 of 10 principal pigs and all 9 sentinel pigs had dysentery; 1 pig died.(ABSTRACT TRUNCATED AT 250 WORDS)     

Efficacy of in-feed medication with tylosin for the treatment and control of Mycoplasma hyopneumoniae infections

The efficacy of in-feed medication with tylosin for the treatment of enzootic pneumonia was examined in an experimental Mycoplasma hyopneumoniae infection model. One group of 10 conventional M. hyopneumoniae-free pigs was inoculated intratracheally with a highly virulent field isolate of M. hyopneumoniae; a second group of 10 pigs was inoculated in the same way and after 12 days was given tylosin at 100 mg/kg feed for 21 days; a third group of 10 pigs was inoculated with sterile culture medium, and these pigs were not given tylosin. The pigs were examined daily for clinical signs and each pig was given a respiratory disease score. Thirty-three days after they had been infected the pigs were euthanased, the lung lesions were quantified and samples of lung were processed for immunofluorescence testing for M. hyopneumoniae. The mean (sd) respiratory disease and lung lesion scores were significantly higher (P<0.05) in both the infected groups than in the uninfected group. Between 23 and 33 days after infection the mean respiratory disease score of the pigs treated with tylosin was 0.54 (0.22), significantly (P<0.05) lower than that of the infected pigs which were left untreated, 1.54 (0.46); similarly, their average lung lesion score, 1.72 (1.20), was significantly lower than that of the untreated pigs, 5.27 (3.85).     

In vivo transfer of an Escherichia coli enterotoxin plasmid possessing genes for drug resistance.

Experiments were conducted to study transfer of an enterotoxin (Ent) plasmid from a porcine enteropathogenic Escherichia coli to an E coli K12 strain in the intestine of newly weaned pigs. The Ent plasmid carried genes for resistance to tetracycline, streptomycin, and sulfonamides, thereby permitting a selection for tetracycline-resistant exconjugants in the feces of the pigs. In vivo transfer of the Ent plasmid was demonstrated to occur when the pigs were given large oral inocula of donor and recipient cultures, 1 hour apart. Differences in extent of transfer were not detected in pigs given antibiotic-free feed compared with littermates on feed containing oxytetracycline at 50 g/ton. In one experiment, tetracycline-resistant Ent- exconjugants were found which appeared to have received an R plasmid from an enteropathogenic type of E coli resident in the intestine.     

Multiple antibiotic resistance in fecal, cecal and colonic coliforms from pigs fed therapeutic and subtherapeutic concentrations of chlortetracycline

Multiple resistance and antibiotic resistance were examined in coliforms isolated at slaughter from the large intestines of two groups of growing pigs that had received antibiotic-free diets since weaning. One group of pigs was from an antibiotic-fed (AB) herd that routinely received chlortetracycline (CTC) in feed, while the other group was from a nonantibiotic-fed (NAB) herd that had not received antibiotics for 8 yr. After a 20-d adjustment period in a common production facility, the mean number of antibiotics in the resistant pattern of isolates from NAB pigs was found to be lower (P less than .05) than that in isolates from AB pigs. The proportions of isolates resistant to ampicillin, kanamycin, neomycin, penicillin, streptomycin and sulfamethizole were lower (P less than .05) in NAB pigs than in AB pigs. Similar herd differences were not observed after pigs from both herds were maintained in a common production facility on an antibiotic-free diet for 105 d. Oral administration of CTC at therapeutic (220 micrograms/g of diet) and at subtherapeutic (27.5 micrograms/g) levels for 14 d increased (P less than .05) the mean numbers of antibiotics in the resistance patterns of isolates from NAB pigs, but did not alter multiple resistance in isolates from AB pigs. After 14 d, subtherapeutic CTC increased the percentage of isolates resistant to ampicillin, kanamycin, penicillin, streptomycin, tetracycline and sulfamethizole, while therapeutic CTC only increased the percentage of isolates from NAB pigs resistant to penicillin, tetracycline and sulfamethizole. Similar antibiotic effects were not seen in isolates from AB pigs after 14 d and were not seen in isolates from either group of pigs at the end of an 85-d feeding trial.     

Prevention of pleuropneumonia in pigs by in-feed medication with sulphadimethoxine and sulphamethoxazole in combination with trimethoprim

The prophylactic effect of in-feed medication of conventional pigs with sulphadimethoxine (SDM), sulphamethoxazole (SMX), and trimethoprim (TMP) was tested by using an Actinobacillus pleuropneumoniae infection model. In each of five experiments, six pigs were given medicated feed twice daily and three pigs received antibiotic-free feed and served as positive (unmedicated, infected) controls. The following drugs or drug combinations were tested (in mg per kg feed): 500 SDM + 100 TMP, 500 SMX + 100 TMP, 125 SMX + 25 TMP, 125 SMX (alone) and 25 TMP (alone). After six days of feed medication, all animals were endobronchially inoculated with A. pleuropneumoniae in a dose of 1-3.10(4) colony-forming units (CFU). The response to the challenge in all control pigs was characterized by fever, lethargy, anorexia, reduced water consumption, and laboured breathing. At autopsy all controls manifested a fibrinous haemorrhagic pleuropneumonia. In-feed medication with 500 SDM + 100 TMP, 500 SMX + 100 TMP as well as 125 SMX + 25 TMP resulted in an effective protection against the challenge in all treated animals. After consumption of feed medicated with 125 mg per kg SMX or 25 mg per kg TMP, pleuropneumonia was evident in all challenged pigs. The results of this study indicate an in vivo potentiation of SMX and TMP in pigs against this respiratory tract pathogen.     

Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments

Effects of danofloxacin or consecutive fluoroquinolone and macrolide treatments on resistance development in Campylobacter have remained uncharacterised. Therefore we analysed the development of resistance in porcine Campylobacter coli before and after danofloxacin and tylosin treatments at a farrowing farm. Danofloxacin-treated (n=12, group A) and control pigs (n=15, group B) were subsequently treated with tylosin and sampled longitudinally. C. coli were isolated and susceptibilities to ciprofloxacin and erythromycin were assessed, isolates were genotyped with PFGE and resistance-related mutations were identified. Isolates from the danofloxacin-treated pigs had more frequently non-wild type MICs (above the epidemiological cut-off value (ECOFF)) for ciprofloxacin (P<0.001) and erythromycin (P<0.05) than those isolated before danofloxacin or those from the controls. Subsequent tylosin treatment increased proportion of isolates with non-wild type MICs for erythromycin in both groups A and B (P<0.01) and, interestingly, proportion of isolates with non-wild type MICs for ciprofloxacin in group B (P<0.001) with high MICs (128 μg/ml). PFGE analysis revealed treatments selecting predominant genotypes with variable resistance patterns and decreasing initial diversity of genotypes. The most common genotype had mainly high MICs for ciprofloxacin among danofloxacin-treated pigs but wild type MICs (below the ECOFF) among the controls housed in the same pens. This suggests that the non-wild type isolate was rarely transmitted or outcompeting wild type genotype in the control pigs without selection pressure. Isolates exhibiting non-wild type MICs for ciprofloxacin harboured the C257T (Thr-86-Ile) mutation in the gyrA gene. In conclusion, a high dose of danofloxacin used at the farm did not prevent emergence of isolates with high MICs for ciprofloxacin. After subsequent tylosin treatment isolates had even higher MICs for ciprofloxacin and erythromycin than before the treatment. Therefore, controlled use of antimicrobials in food animal production is essential.     

Antibiotic resistance of fecal coliforms from swine fed subtherapeutic and therapeutic levels of chlortetracycline

The effect of feeding subtherapeutic (27.5 micrograms/g of diet for 85 d) and therapeutic (220 micrograms/g of diet for 14 d, followed by an antibiotic-free diet for 71 d) levels of chlortetracycline (CTC) on the antibiotic resistance of fecal coliforms of pigs from two herds (36 pigs/herd) with different histories of antibiotic exposure when housed in a newly constructed confinement facility was determined. The CTC-resistant coliforms were higher (65 vs 51%) for antibiotic (AB) pigs than for nonantibiotic (NAB) pigs after they had been fed an antibiotic-free diet for 21 d. Percentages of isolates resistant to ampicillin, kanamycin, neomycin and tetracycline and multiple antibiotic resistance were greater (P less than .05) in AB pigs after 21 d. Feeding subtherapeutic CTC resulted in a linear increase in CTC-resistant coliforms with time on experiment (P less than .03, NAB; P less than .06, AB). The CTC-resistant coliforms increased during the 14 d that therapeutic CTC was fed, then they decreased during the 71 d that the antibiotic-free diet was fed, resulting in a quadratic response with time (P less than .03, AB). Feeding subtherapeutic CTC resulted in a greater increase in CTC-resistant coliforms in AB (47%) than in NAB (23%) pigs. The CTC-resistant coliforms decreased after the therapeutic group had been returned to the antibiotic-free diet (P less than .05, NAB). Feeding CTC caused greater changes in the precentages of isolates from NAB pigs that were resistant to selected antibiotics and in multiple antibiotic resistance than in isolates from AB pigs.(ABSTRACT TRUNCATED AT 250 WORDS)     

Macrolides and lincomycin susceptibility of Mycoplasma hyorhinis and variable mutation of domain II and V in 23S ribosomal RNA

A total of 151 strains of Mycoplasma hyorhinis isolated from porcine lung lesions (weaned pigs, n=71, and finishers, n=80) were investigated for their in vitro susceptibility to 10 antimicrobial agents. Thirty-one strains (28 from weaned pigs and 3 from finishers) showed resistance to 16-membered macrolide antibiotics and lincomycin. The prevalence of the 16-membered macrolide-resistant M. hyorhinis strain in weaned pigs from Japanese herds has approximately quadrupled in the past 10 years. Several of the 31 strains were examined for mutations in the 23S ribosomal RNA (rRNA). All field strains tested showed a transition of A to G at position 2059 of 23S rRNA-rendered Escherichia coli. On the other hand, individual tylosin- and lincomycin-resistant mutants of M. hyorhinis were selected in vitro from the susceptible type strain BTS7 by 3 to 9 serial passages in subinhibitory concentrations of each antibiotic. The 23S rRNA sequences of both tylosin and lincomycin-resistant mutants were compared with that of the radical BTS7 strain. The BTS7 mutant strain selected by tylosin showed the same transition as the field-isolated strains of A2059G. However, the transition selected in lincomycin showed mutations in domains II and V of 23S rRNA, G2597U, C2611U in domain V, and the addition of an adenine at the pentameric adenine loop in domain II. The strain selected by lincomycin showed an additional point mutation of A2062G selected by tylosin.     

Prevalence and in-vitro antimicrobial sensitivity of Bordetella bronchiseptica in the nasal cavity of pigs

The prevalence of Bordetella bronchiseptica in the nasal cavity of pigs and the in-vitro sensitivity of isolates to a variety of antimicrobial agents was investigated. B.Bronchiseptica was recovered from 372 nasal swabs collected from 1000 (37.2%) pigs slaughtered at 20-30 weeks old at an abattoir. The swabs were collected from groups of 5-206 pigs derived from 25 herds. All isolates tested against bacitracin, clindamycin, furazolidone, penicillin, spectinomycin, streptomycin and tylosin were found to be resistant. Of the 372 isolates tested against ampicillin and erythromycin 22 (6%) were sensitive to the former and 365 (98%) were moderately sensitive to the latter, the remainder were resistant. All isolates tested against neomycin and tetracycline were sensitive and with few exceptions, (2%), they were also sensitive to chloramphenicol. Overall, 259 of the 372 (70%) isolates were sensitive to sulphonamides, identical results being obtained with sulphadiazine, sulphafurazole and a trimethoprim-sulphamethoxazole combination. An association between in-vitro resistance to sulphanomides and extensive use of this group of drugs was demonstrated on three of eight farms investigated.     

Growth performance of pigs fed diets with and without tylosin phosphate supplementation and reared in a biosecure all-in all-out housing system

Three hundred and eighty-four pigs, mean initial live weight of 20.8 kg, were assigned randomly to groups of 24 (12 females, 12 castrated males). Each group was randomly assigned to 1 of 2 dietary treatments consisting of the same commercial barley-based diet, with or without the addition of tylosin phosphate. The barn where the animals were housed operates as an all-in all-out facility, and all pigs arrived on the same day as part of a group of 960 pigs. No new pigs were introduced into the facility during the period of this trial and pigs were sent to market over a 4-week period upon achieving a live weight of 110 kg. The pigs were weighed at the beginning of the trial and when they left the facility for slaughter. Feed consumption and incidence of disease, mortality, or both were recorded daily. At slaughter, carcass backfat depth over the last rib, 6.5 cm ventral to the dorsal midline (P-2 site); loin depth; carcass weight; predicted lean yield; and grade index were recorded. The sow herd supplying pigs to the unit was known to be free of the major swine diseases such as swine influenza, mycoplasma pneumonia, porcine reproductive and respiratory syndrome (PRRS), necroproliferative enteritis, and ascarids. A strict biosecurity protocol was employed to minimize the risk of introducing disease organisms into the unit. Prior to this study, no subtherapeutic antibiotics had been used in this facility. Tylosin phosphate supplementation had no significant effect on final weight, days on test, total gain, and daily gain. In both treatments, the pigs reached a mean market weight of 110.2 kg within 94.1 days, resulting in daily gains of the order of 950 grams per day. Due to the design of the trial, it was difficult to measure significant feed consumption effects. Feed consumption and conversion appeared to be similar for pigs in both treatment groups. At slaughter, tylosin phosphate supplementation appeared to significantly increase lean muscle content of the carcass as measured by loin muscle depth (P = 0.04). Mortality rates and the number of underweight pigs sent to market were low for this trial. Mortality was similar for both treatments; however, more of the control pigs than of the tylosin phosphate fed pigs were underweight when sent to market. From the results of this study, it appears that pigs of fast growing genotypes fed adequate diets and housed in a biosecure environment do not require dietary tylosin phosphate supplementation in order to maximize growth. There is some indication that tylosin phosphate supplementation may improve lean content of the carcass in pigs housed in such an environment.     

长期饲喂发酵全价饲料对猪生长、粪便臭味物质、血清抗氧化及免疫性能指标的影响

本试验旨在研究长期饲喂发酵全价饲料对生长猪生长性能、粪便臭味物质、血清抗氧化及免疫性能相关指标的影响。试验以地衣芽孢杆菌和乳酸菌为混合发酵菌剂制备发酵全价饲料。选择90头22 kg左右的约荣二元杂交猪,随机分成3组,每组6个重复,每个重复5头猪,分别饲喂无抗饲料(对照组),含抗生素的饲料(抗生素组)和发酵全价饲料(发酵组)。饲喂2个月后,测定各试验组猪的生长性能、粪便pH、挥发性臭味物质的含量及血清抗氧化指标、免疫球蛋白水平。结果显示:①全价饲料经发酵后,总抗氧化能力(T-AOC)极显著提高(P<0.01),还原力和羟自由基清除力均有升高趋势(P>0.05)。②饲喂两个月发酵全价饲料对各组猪的平均日采食量(ADFI)、平均日增重(ADG)、料重比(F/G)影响均不显著(P>0.05)。③各组猪的粪便pH及对甲酚、吲哚、粪臭素、乙酸、丙酸、丁酸、戊酸含量差异均不显著(P>0.05),但发酵组的异戊酸含量显著低于抗生素组(P<0.05)。④各组猪的血清超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)和过氧化氢酶(CAT)活性,T-AOC及丙二醛(MDA)含量差异均不显著(P>0.05);与对照组相比,发酵组血清免疫球蛋白M(IgM)水平有升高趋势,但差异不显著(P>0.05),补体蛋白4(C4)含量显著升高(P<0.05),这两项指标与抗生素组相比差异不显著(P>0.05)。综合试验结果,长期饲喂发酵全价饲料对猪生长,粪便pH,粪便主要臭味物质含量及血清抗氧化指标、IgG、IgM水平没有显著影响,没有延续短期饲喂的优势。     

Experimental infection of pigs with a thymidine kinase negative strain of pseudorabies virus

Sixteen 20 day old pigs, devoid of neutralizing antibody to pseudorabies virus (PRV), were divided into two groups of eight, and the animals of each group were housed in a separate unit. In each group 6 pigs were inoculated intranasally with the thymidine kinase (TK⁻) mutant (Group 1) or the field strain of PRV (Group 2), each pig receiving an inoculum of 4 ml. The remaining 2 pigs in each group served as uninoculated controls. The only clinical sign observed in the pigs of Group 1 was a transient febrile reaction, in the case of six pigs inoculated with the TK⁻ mutant of PRV, whereas no signs of disease were seen in the uninoculated controls. The virus was isolated from the 6 infected pigs of the group only on post infection day (PID) 2, whereas it was never isolated from the controls. By contrast, the pigs of Group 2, had a severe clinical response and one, among those that were inoculated with the field strain of the PRV, died on PID 9. Virus was consistently isolated from all pigs of Group 2, inoculated and control. On PID 30 all pigs, i.e. the 8 of Group 1 and 7 of the Group 2 which survived to the infection, were subjected to dexamethasone (DMS) treatment. After DMS treatment virus was never isolated from the nasal swabbings obtained from the pigs of Group 1, whereas it was consistently isolated from pigs of Group 2. After 30 d from the start of DMS treatment the pigs were killed and several tissues were collected from each pig for virus detection, by isolation in tissue culture and by PCR analysis. At necropsy no lesions were found in pigs of Group 1, whereas acute pneumonia and gliosis in the trigeminal ganglia were observed in pigs of Group 2. Virus was never isolated from any of the tissues taken from pigs of both, Group 1 and Group 2, nevertheless sequences of PRV were detected by PCR analysis in the trigeminal ganglia of the pigs of both Groups.     

Characterization of in vivo-acquired resistance to macrolides of Mycoplasma gallisepticum strains isolated from poultry

ABSTRACT: The macrolide class of antibiotics, including tylosin and tilmicosin, is widely used in the veterinary field for prophylaxis and treatment of mycoplasmosis. In vitro susceptibility testing of 50 strains of M. gallisepticum isolated in Israel during the period 1997-2010 revealed that acquired resistance to tylosin as well as to tilmicosin was present in 50% of them. Moreover, 72% (13/18) of the strains isolated from clinical samples since 2006 showed acquired resistance to enrofloxacin, tylosin and tilmicosin. Molecular typing of the field isolates, performed by gene-target sequencing (GTS), detected 13 molecular types (I-XIII). Type II was the predominant type prior to 2006 whereas type X, first detected in 2008, is currently prevalent. All ten type X strains were resistant to both fluoroquinolones and macrolides, suggesting selective pressure leading to clonal dissemination of resistance. However, this was not a unique event since resistant strains with other GTS molecular types were also found. Concurrently, the molecular basis for macrolide resistance in M. gallisepticum was identified. Our results revealed a clear-cut correlation between single point mutations A2058G or A2059G in domain V of the gene encoding 23S rRNA (rrnA, MGA_01) and acquired macrolide resistance in M. gallisepticum. Indeed, all isolates with MIC ≥ 0.63 μg/mL to tylosin and with MIC ≥ 1.25 μg/mL to tilmicosin possess one of these mutations, suggesting an essential role in decreased susceptibility of M. gallisepticum to 16-membered macrolides.     

Effect of feeding regimen on behavior of growing-finishing pigs supplemented or not supplemented with folic acid.

The effect of restricted feeding on the frequency of abnormal behaviors and gastric ulcers was investigated in 72 market pigs. Half of the pigs were fed restricted (R) amounts of feed twice a day (0800 and 1600) and received 90 to 95% of the intake recorded for the other half, which were allowed ad libitum (A) access to feed with addition of feed once a day at 0800. In each feeding group, 24 pigs were supplemented with folic acid. The animals were housed in pairs and the behavior of each animal was recorded during 24 h at 18 and 20 wk of age. The results showed that the A group ate more frequently during light hours than the R group at 18 wk, but not at 20 wk. However, the frequency of eating behavior was higher in the R group than in the A group at 20 wk during the 2 h after feed distribution. Feeding regimen had an effect on the frequency of redirected behaviors during the 2 h preceding feed distribution. The percentage of time spent nibbling on the penmate was higher in R than in A pigs at 18 wk, whereas that of rooting on the penmate was higher at 20 wk. Moreover, the proportion of pigs performing redirected behaviors was higher in the R than in the A group at both ages. The overall frequency of gastric ulcers was similar in pigs given the two feeding treatments, but severe ulcers were more frequent in the R than in the A group. Some interactions were also found between feeding regimen and folic acid.(ABSTRACT TRUNCATED AT 250 WORDS)     

Nutrient digestibility, blood profiles and fecal microbiota are influenced by chitooligosaccharide supplementation of growing pigs

This study was conducted to evaluate the effects of dietary chitooligosaccharide (COS) supplementation on growth performance, nutrient digestibility, blood profiles and fecal microbiota in growing pigs. A total of 144 [(Landrace × Yorkshire) × Duroc] pigs with an initial body weight of 23.6 ± 1.1 kg were allotted to one of the following dietary treatments: 1) basal diet; 2) basal diet with 44 mg/kg of tylosin (100 mg/kg tylosin); 3) basal diet with 5 g/kg of COS and 4) basal diet with 5 g/kg COS and 44 mg/kg tylosin. There were nine replications per treatment with four pigs per pen. Throughout the experiment, pigs that were treated with a combination of COS and tylosin had a lower ADFI (P = 0.02) and higher gain/feed ratio (P < 0.05) than the other treatments. In addition, administration of either COS or tylosin alone significantly increased the digestibility of dry matter, nitrogen and gross energy (P < 0.05). The red blood cell (RBC) and white blood cell (WBC) counts, as well as the serum albumin concentrations were not affected by COS or tylosin supplementation. However, the lymphocyte proportion and serum total protein concentration were increased in pigs fed tylosin supplemented diets compared with those pigs fed diets not supplemented with tylosin (P < 0.05). Administration of tylosin significantly increased serum IgG concentration (P = 0.02); however, treatment with COS or tylosin supplementation had no effect on the total cholesterol or triglyceride concentrations. The serum HDL cholesterol concentration was significantly increased in pigs treated with COS (P = 0.02) compared to the pigs fed diets without COS. The COS administration also decreased the number of fecal Escherichia coli (P < 0.01), whereas the number of fecal Lactobacilli was not influenced by either COS or tylosin administration. Results of the current study indicate that dietary supplementation of COS can improve nutrient digestibility and haematological profiles, as well as decrease of fecal E. coli populations in growing pigs.     

Effect of wean-to-finish management on pig performance

In each of three trials, 240 crossbred barrows weaned at 17 d of age (5.1 kg BW) were assigned to one of three experimental treatments based on light and heavy weight outcome groups. Experimental treatments were 1) wean-to-finish at 0.69 m2/pig and 15 pigs/pen; 2) wean-to-finish double-stocked at 0.35 m2/pig, 30 pigs per pen for 8 wk and then randomly split into two pens (either stayed in same pen or moved to new pen) for growth to slaughter at 0.69 m2/pig; and 3) nursery facility for 8 wk at 0.35 m2/pig and 15 pigs/pen followed by move to the same grow-finish facility housing wean-to-finish and double-stocked pigs and maintaining pen integrity. Beginning at 38 kg BW, diets were supplemented with either bacitracin methylenedisalicylate at 33 mg/kg to slaughter or tylosin at 44 mg/kg to 59 kg BW and 22 mg/kg thereafter. There were no trial x treatment interactions, even though there was considerable variation in health status among trials. At the end of the 56-d nursery period, wean-to-finish pigs weighed more than nursery (28.7 vs 27.7 kg; P = 0.071) and double-stocked pigs (28.7 vs 26.9 kg; P = 0.002), due to greater ADG (wean-to-finish vs nursery; P = 0.062; wean-to-finish vs double-stocked; P = 0.002) and greater ADFI (wean-to-finish vs nursery; P = 0.024; wean-to-finish vs double-stocked, P = 0.002). There was no effect of treatments (P > 0.1) on ADG, feed conversion, carcass lean percentage, or lean gain during the growing-finishing period. There was also no effect of treatment (P > 0.1) on ADG or ADFI from weaning to slaughter. There was no difference (P > 0.1) between bacitracin methylenedisalicylate and tylosin for ADG, feed conversion, carcass lean percentage, or daily lean gain. These data suggest that housing 5-kg weaned pigs in fully slatted growing-finishing facilities from weaning to slaughter was not detrimental to overall performance. In this experiment, dietary additions of bacitracin methylenedisalicylate or tylosin from 38 kg BW to slaughter weight resulted in similar growth performance.     

In vitro development of resistance to enrofloxacin,erythromycin, tylosin,tiamulin and oxytetracycline in Mycoplasma gallisepticum,Mycoplasma iowae and Mycoplasma synoviae

The in vitro emergence of resistance to enrofloxacin, erythromycin, tylosin, tiamulin, and oxytetracycline in three avian Mycoplasma species, Mycoplasma gallisepticum, Mycoplasma synoviae and Mycoplasma iowae was studied. Mutants were selected stepwise and their MICs were determined after 10 passages in subinhibitory concentrations of antibiotic. High-level resistance to erythromycin and tylosin developed within 2-6 passages in the three Mycoplasma species. Resistance to enrofloxacin developed more gradually. No resistance to tiamulin or oxytetracycline could be evidenced in M. gallisepticum or M. synoviae after 10 passages whereas, resistant mutants were obtained with M. iowae. Cross-sensitivity tests performed on mutants demonstrated that mycoplasmas made resistant to tylosin were also resistant to erythromycin, whereas mutants made resistant to erythromycin were not always resistant to tylosin. Some M. iowae tiamulin-resistant mutants were also resistant to both macrolide antibiotics. Enrofloxacin and oxytetracycline did not induce any cross-resistance to the other antibiotics tested. These results show that Mycoplasma resistance to macrolides can be quickly selected in vitro, and thus, providing that similar results could be obtained under field conditions, that development of resistance to these antibiotics in vivo might also be a relatively frequent event.